pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 1
    EBC-129
    Pancreatic Ductal Adenocarcinoma Agency for Science, Technology and Research
  • Phase 2
    EEDVD-682
    Pancreatic Ductal Adenocarcinoma EnGeneIC Ltd
  • Phase 2
    EF-001
    Anaplastic Astrocytoma Everfront Biotech Inc
  • Phase 2
← prev
page 18 of 62
next →
Pain89
Neurology1
EG-007
Endometrial Cancer
Shenzhen Evergreen Therapeutics Co Ltd
  • Preclinical
    EIR-1003
    Neovascular Glaucoma EIR Biopharma Inc
  • Phase 2
    EIS-12656
    Breast Cancer Eisbach Bio GmbH
  • Phase 2
    ELI-002 2P
    Colorectal Cancer$ELTX Elicio Therapeutics, Inc.
  • Phase 1
    ELVN-001
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)$ELVN Enliven Therapeutics, Inc.
  • Phase 2
    ELVN-002
    Human Epidermal Growth Factor Receptor 2 Positive Breast…$ELVN Enliven Therapeutics, Inc.
  • Phase 2
    ENB-003
    Pancreatic Cancer ENB Therapeutics LLC
  • Phase 2
    EO-2463
    Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat… Enterome Bioscience SA
  • Preclinical
    EPS-401
    Non-Small Cell Lung Cancer Epsilogen Ltd
  • Phase 1
    ERAS-4001
    Solid Tumor$ERAS Erasca, Inc.
  • Phase 2
    ERC-1671
    Gliovac
    Gliosarcoma ERC Belgium SA
  • Preclinical
    ERNA-101
    Ovarian Cancer$ERNA Ernexa Therapeutics Inc.
  • Phase 1
    ERSM-5404
    Colorectal Cancer Hibercell Inc
  • Phase 2
    ET-1402
    Hepatocellular Carcinoma Eureka Therapeutics Inc
  • Phase 2
    ETX-19477
    Ovarian Cancer 858 Therapeutics Inc
  • Phase 2
    ETX-636
    Human Epidermal Growth Factor Receptor 2 Negative Breast… ENSEM Therapeutics Inc
  • Phase 2
    EU-101
    Colorectal Cancer Eutilex Co Ltd
  • Phase 2
    EVM-14
    Esophageal Squamous Cell Carcinoma (ESCC) Everest Medicines Ltd
  • Phase 1
    EVOLVE-104
    Anal Cancer EvolveImmune Therapeutics Inc
  • Phase 2
    EVX-01
    Metastatic Melanoma$EVAX Evaxion A/S
  • Preclinical
    EX-501
    Unspecified Cancer Exinda Therapeutics LLC
  • Preclinical
    Engineered Virus
    Glioblastoma Multiforme (GBM) Kopra Bio Inc
  • Phase 2
    FB-849
    Solid Tumor 1st Bio Therapeutics Inc
  • Phase 2
    FF-10502-01
    Solid Tumor Fujifilm Holdings Corp
  • Phase 3
    FG-3246
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$KYNB KYNTRA BIO, INC.
  • Preclinical
    FID-021
    Unspecified Cancer Fulgent Pharma LLC
  • Phase 1
    FID-022
    Solid Tumor Fulgent Pharma LLC